ClinicalTrials.Veeva

Menu

Collection of Cerebrospinal Fluid in Healthy Children

Weill Cornell Medicine (WCM) logo

Weill Cornell Medicine (WCM)

Status

Terminated

Conditions

Late Infantile Neuronal Ceroid Lipofuscinosis
Batten Disease

Treatments

Other: Group 1

Study type

Observational

Funder types

Other

Identifiers

NCT01698229
1111012024

Details and patient eligibility

About

The purpose of this study is to obtain cerebrospinal fluid from healthy children already undergoing a lumbar puncture procedure at New York Presbyterian Hospital, to act as healthy controls when compared to children with late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal neurodegenerative disease.

Full description

obtain cerebrospinal fluid from healthy children already undergoing a lumbar puncture procedure at New York Presbyterian Hospital, to act as healthy controls when compared to children with late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal neurodegenerative disease.

Enrollment

32 patients

Sex

All

Ages

2 to 8 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Males and females, ages 2 yrs to 8 yrs
  • Children already undergoing a lumbar puncture procedure for clinical or diagnostic purposes

Exclusion criteria

  • Presence of any significant neurological diseases, as judged by the co-investigators
  • Presence of any significant medical conditions including cancer

Trial design

32 participants in 1 patient group

Group 1
Description:
Study cohort is comprised of healthy children, ages 2yrs - 8yrs, who are already undergoing a lumbar puncture procedure at New York Presbyterian Hospital for clinical or diagnostic purposes.
Treatment:
Other: Group 1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems